Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Izumi (Kiyose, Tokyo, Japan). Late Breaking Abstract - Spatial distribution and environmental risk factors of nontuberculous mycobacterial pulmonary disease in Japan. 2594

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Pulmonary tuberculosis relapse: predisposing factors and management in Tunisia Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors. Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017 Year: 2018 Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids? Source: International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases Year: 2014 Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Latent class analysis of CT patterns in pulmonary non-tuberculous mycobacterial infection Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs Source: Eur Respir J , 49 (4)  1700374; DOI: 10.1183/13993003.00374-2017 Year: 2017 Remarkable diversity in the geographic distribution of NTM species in Bursa, Turkey: Analysis of nontuberculous mycobacterial pulmonary disease in a two years retrospective cohort Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Geographic origin and other determinants of site of tuberculosis disease in European countries Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Characteristics and risk factors for missed pulmonary tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018 Burden of non-tuberculous mycobacterial pulmonary disease in Germany Source: Eur Respir J , 49 (4)  1602109; DOI: 10.1183/13993003.02109-2016 Year: 2017 Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014